{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:44:35Z","timestamp":1792640675745,"version":"4.5.0"},"reference-count":56,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Allogeneic hematopoietic cell transplantation (allo-HCT) is a highly complex, costly procedure for patients with oncologic, hematologic, genetic, and immunologic diseases. Demographics and socioeconomic status as well as donor availability and type of health care system are important factors that influence access to and outcomes following allo-HCT. The last decade has seen an increase in the numbers of allo-HCTs and teams all over the world, with no signs of saturation. More than 80 000 procedures are being performed annually, with 1 million allo-HCTs estimated to take place by the end of 2024. Many factors have contributed to this, including increased numbers of eligible patients (older adults with or without comorbidities) and available donors (unrelated and haploidentical), improved supportive care, and decreased early and late post-HCT mortalities. This increase is also directly linked to macro- and microeconomic indicators that affect health care both regionally and globally. Despite this global increase in the number of allo-HCTs and transplant centers, there is an enormous need for increased access to and improved outcomes following allo-HCT in resource-constrained countries. The reduction of poverty, global economic changes, greater access to information, exchange of technologies, and use of artificial intelligence, mobile health, and telehealth are certainly creating unprecedented opportunities to establish collaborations and share experiences and thus increase patient access to allo-HCT. A specific research agenda to address issues of allo-HCT in resource-constrained settings is urgently warranted.<\/jats:p>","DOI":"10.1182\/hematology.2021000258","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T07:11:09Z","timestamp":1639120269000},"page":"264-274","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":39,"title":["Increasing access to allogeneic hematopoietic cell transplant: an international perspective"],"prefix":"10.1182","volume":"2021","author":[{"given":"Vanderson","family":"Rocha","sequence":"first","affiliation":[{"name":"Laboratorio de Investiga\u00e7\u00e3o M\u00e9dica (LIM) 31, Servi\u00e7o de Hematologia e Terapia Celular, Hospital das Cl\u00ednicas, Faculdade de Medicina, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"},{"name":"Eurocord, Paris, France"},{"name":"Hospital Vila Nova Star - Rede D\u2019Or, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Fatobene","sequence":"additional","affiliation":[{"name":"Laboratorio de Investiga\u00e7\u00e3o M\u00e9dica (LIM) 31, Servi\u00e7o de Hematologia e Terapia Celular, Hospital das Cl\u00ednicas, Faculdade de Medicina, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"},{"name":"Eurocord, Paris, France"},{"name":"Hospital Vila Nova Star - Rede D\u2019Or, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietger","family":"Niederwieser","sequence":"additional","affiliation":[{"name":"University of Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Brazilian Society of Bone Marrow Transplantation and the Worldwide Network for Blood and Marrow Transplantation","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"issue":"8","key":"2021121012064779400_hem2021000258C1","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.bbmt.2009.12.529","article-title":"Access to hematopoietic cell transplantation in the United States","volume":"16","author":"Majhail","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2021121012064779400_hem2021000258C2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2471\/BLT.12.116988","article-title":"Globally consistent coding systems for medical products of human origin","volume":"91","author":"Warwick","year":"2013","journal-title":"Bull World Health Organ"},{"key":"2021121012064779400_hem2021000258C3","unstructured":"World Health Organization. WHO guiding principles on human cell, tissue and organ transplantation. Accessed 19October2021. https:\/\/www.who.int\/transplantation\/Guiding_PrinciplesTransplantation_WHA63.22en.pdf."},{"issue":"3","key":"2021121012064779400_hem2021000258C4","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/S2352-3026(15)00028-9","article-title":"One million haemopoietic stem-cell transplants: a retrospective observational study","volume":"2","author":"Gratwohl","year":"2015","journal-title":"Lancet Haematol"},{"key":"2021121012064779400_hem2021000258C5","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2021.279189","article-title":"One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors","author":"Niederwieser","year":"2021","journal-title":"Haematologica"},{"issue":"6","key":"2021121012064779400_hem2021000258C6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/bmt.2016.18","article-title":"Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey","volume":"51","author":"Niederwieser","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2021121012064779400_hem2021000258C7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"key":"2021121012064779400_hem2021000258C8","doi-asserted-by":"crossref","first-page":"584950","DOI":"10.3389\/fimmu.2020.584950","article-title":"How ancestry influences the chances of finding unrelated donors: an investigation in admixed Brazilians","volume":"11","author":"Nunes","year":"2020","journal-title":"Front Immunol"},{"issue":"10","key":"2021121012064779400_hem2021000258C9","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.bbmt.2019.06.012","article-title":"Inferior access to allogeneic transplant in disadvantaged populations: a Center for International Blood and Marrow Transplant Research analysis","volume":"25","author":"Paulson","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2021121012064779400_hem2021000258C10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41409-017-0026-z","article-title":"Access to alternative donor hematopoietic search and transplantation for acute leukemia in different macro-regions of Italy: a GITMO\/IBMDR study","volume":"53","author":"Milone","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2021121012064779400_hem2021000258C11","doi-asserted-by":"crossref","first-page":"e039293","DOI":"10.1136\/bmjopen-2020-039293","article-title":"Utilisation and outcomes of allogeneic hematopoietic cell transplantation in Ontario, Canada, and New York State, USA: a population-based retrospective cohort study","volume":"10","author":"Hershenfeld","year":"2020","journal-title":"BMJ Open"},{"issue":"10","key":"2021121012064779400_hem2021000258C12","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41409-018-0164-y","article-title":"Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia","volume":"53","author":"Bhatt","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"14","key":"2021121012064779400_hem2021000258C13","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1002\/cncr.25297","article-title":"Access to hematopoietic stem cell transplantation: effect of race and sex","volume":"116","author":"Joshua","year":"2010","journal-title":"Cancer"},{"issue":"7","key":"2021121012064779400_hem2021000258C14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1182\/bloodadvances.2018028662","article-title":"Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis","volume":"3","author":"Barker","year":"2019","journal-title":"Blood Adv"},{"issue":"4","key":"2021121012064779400_hem2021000258C15","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1182\/blood.2020006252","article-title":"Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis","volume":"137","author":"Bona","year":"2021","journal-title":"Blood"},{"issue":"2","key":"2021121012064779400_hem2021000258C16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/bmt.2015.246","article-title":"Geographic access to hematopoietic cell transplantation services in the United States","volume":"51","author":"Delamater","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2021121012064779400_hem2021000258C17","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.bbmt.2016.03.019","article-title":"Association of distance from transplantation center and place of residence on outcomes after allogeneic hematopoietic cell transplantation","volume":"22","author":"Khera","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2021121012064779400_hem2021000258C18","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41409-020-01184-8","article-title":"Impact of access to care on 1-year mortality following allogeneic blood or marrow transplantation","volume":"56","author":"Jamy","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2021121012064779400_hem2021000258C19","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.bbmt.2018.09.030","article-title":"Positive psychological constructs and health outcomes in hematopoietic stem cell transplantation patients: a systematic review","volume":"25","author":"Amonoo","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"32","key":"2021121012064779400_hem2021000258C20","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1200\/JCO.2017.73.2800","article-title":"Effect of inpatient palliative care during hematopoietic stem-cell transplant on psychological distress 6 months after transplant: results of a randomized clinical trial","volume":"35","author":"El-Jawahri","year":"2017","journal-title":"J Clin Oncol"},{"issue":"12","key":"2021121012064779400_hem2021000258C21","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/bmt.2016.191","article-title":"Pre-transplant emotional support is associated with longer survival after allogeneic hematopoietic stem cell transplantation","volume":"51","author":"Ehrlich","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2021121012064779400_hem2021000258C22","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1007\/s00520-019-04696-2","article-title":"Caregiver availability and patient access to hematopoietic cell transplantation: social worker perspectives inform practice","volume":"27","author":"Preussler","year":"2019","journal-title":"Support Care Cancer"},{"issue":"11","key":"2021121012064779400_hem2021000258C23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.bmt.1703676","article-title":"Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program","volume":"30","author":"Frey","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"2021121012064779400_hem2021000258C24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1188\/17.ONF.571-579","article-title":"Hematopoietic stem cell transplantation recipient and caregiver factors affecting length of stay and readmission","volume":"44","author":"Sundaramurthi","year":"2017","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"2021121012064779400_hem2021000258C25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/10428194.2020.1827252","article-title":"A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings?","volume":"62","author":"Silveira","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2021121012064779400_hem2021000258C26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1634\/theoncologist.2015-0314","article-title":"Association of macroeconomic factors with nonrelapse mortality after allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia: an analysis from the Acute Leukemia Working Party of the EBMT","volume":"21","author":"Giebel","year":"2016","journal-title":"Oncologist"},{"issue":"1","key":"2021121012064779400_hem2021000258C27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1182\/blood-2010-01-266478","article-title":"Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia","volume":"116","author":"Giebel","year":"2010","journal-title":"Blood"},{"key":"2021121012064779400_hem2021000258C28","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3389\/fimmu.2020.01537","article-title":"Association of country-specific socioeconomic factors with survival of patients who experience severe classic acute graft-vs.-host disease after allogeneic hematopoietic cell transplantation: an analysis from the Transplant Complications Working Party of the EBMT","volume":"11","author":"Frankiewicz","year":"2020","journal-title":"Front Immunol"},{"issue":"11","key":"2021121012064779400_hem2021000258C29","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/bmt.2016.177","article-title":"Differences in stem cell transplantation activity among regions in Spain: an economic explanation","volume":"51","author":"Espigado","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"2021121012064779400_hem2021000258C30","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.bbmt.2018.03.016","article-title":"Country-level macroeconomic indicators predict early post-allogeneic hematopoietic cell transplantation survival in acute lymphoblastic leukemia: a CIBMTR analysis","volume":"24","author":"Wood","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2021121012064779400_hem2021000258C31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/cncr.33232","article-title":"Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States","volume":"127","author":"Hong","year":"2021","journal-title":"Cancer"},{"key":"2021121012064779400_hem2021000258C32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.6061\/clinics\/2020\/e1566","article-title":"Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience","volume":"75","author":"da Silva","year":"2020","journal-title":"Clinics"},{"issue":"7","key":"2021121012064779400_hem2021000258C33","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.bbmt.2015.01.010","article-title":"Allogeneic hematopoietic cell transplantation for children with sickle cell disease is beneficial and cost-effective: a single-center analysis","volume":"21","author":"Arnold","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2021121012064779400_hem2021000258C34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.hemonc.2017.05.016","article-title":"Establishing an autologous versus allogeneic hematopoietic cell transplant program in nations with emerging economies","volume":"10","author":"Chaudhri","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"6","key":"2021121012064779400_hem2021000258C35","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.hoc.2014.08.007","article-title":"Referral to transplant center for hematopoietic cell transplantation","volume":"28","author":"Majhail","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"2021121012064779400_hem2021000258C36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41409-019-0718-7","article-title":"Benchmarking of survival outcomes following haematopoietic stem cell transplantation: a review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)","volume":"55","author":"Snowden","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2021121012064779400_hem2021000258C37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.hemonc.2019.08.001","article-title":"Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (part I): minimum requirements and beyond","volume":"13","author":"Pasquini","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"10","key":"2021121012064779400_hem2021000258C38","doi-asserted-by":"crossref","first-page":"e17298","DOI":"10.2196\/17298","article-title":"Determining if telehealth can reduce health system costs: scoping review","volume":"22","author":"Snoswell","year":"2020","journal-title":"J Med Internet Res"},{"issue":"23","key":"2021121012064779400_hem2021000258C39","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1200\/JCO.2009.26.8722","article-title":"Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post- traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantation","volume":"28","author":"DuHamel","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"2021121012064779400_hem2021000258C40","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11764-018-0693-9","article-title":"An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation","volume":"12","author":"Syrjala","year":"2018","journal-title":"J Cancer Surviv"},{"issue":"suppl 1","key":"2021121012064779400_hem2021000258C41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2020-143288","article-title":"Telehealth in hematopoietic cell transplantation: perspective from patients at a public hospital in Brazil","volume":"136","author":"Cordeiro","year":"2020","journal-title":"Blood"},{"issue":"suppl 1","key":"2021121012064779400_hem2021000258C42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/bloodadvances.2019GS121781","article-title":"Bridging the gap using telemedicine: optimizing an existing autologous hematopoietic SCT unit into an allogeneic hematopoietic SCT unit in Paraguay with the help of the WBMT","volume":"3","author":"Frutos","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"2021121012064779400_hem2021000258C43","doi-asserted-by":"crossref","first-page":"e26121","DOI":"10.2196\/26121","article-title":"Use of telehealth for domiciliary follow-up after hematopoietic cell transplantation during the COVID-19 pandemic: prospective pilot study","volume":"5","author":"Mussetti","year":"2021","journal-title":"JMIR Form Res"},{"issue":"3","key":"2021121012064779400_hem2021000258C44","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0000000000003425","article-title":"Telemedicine based remote home monitoring after liver transplantation: results of a randomized prospective trial","volume":"270","author":"Lee","year":"2019","journal-title":"Ann Surg"},{"issue":"6","key":"2021121012064779400_hem2021000258C45","first-page":"510","article-title":"Wearable digital thermometer improves fever detection","volume":"318","author":"Abbasi","year":"2017","journal-title":"JAMA"},{"key":"2021121012064779400_hem2021000258C46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fdgth.2020.00006","article-title":"Artificial intelligence for healthcare in Africa","volume":"2","author":"Owoyemi","year":"2020","journal-title":"Front Digit Heal"},{"issue":"8","key":"2021121012064779400_hem2021000258C47","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3324\/haematol.2012.076349","article-title":"Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a global observational study","volume":"98","author":"Gratwohl","year":"2013","journal-title":"Haematologica"},{"issue":"5","key":"2021121012064779400_hem2021000258C48","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/bmt.2016.361","article-title":"Latin America: the next region for haematopoietic transplant progress","volume":"52","author":"Jaimovich","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2021121012064779400_hem2021000258C49","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41409-018-0275-5","article-title":"Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean\/African region: comparison with global HSCT indications and trends","volume":"54","author":"Baldomero","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"16","key":"2021121012064779400_hem2021000258C50","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2010.491","article-title":"Hematopoietic stem cell transplantation: a global perspective","volume":"303","author":"Gratwohl","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"2021121012064779400_hem2021000258C51","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.hemonc.2019.05.003","article-title":"Special report: summary of the first meeting of African Blood and Marrow Transplantation (AfBMT) group, Casablanca, Morocco, April 19\u201321, 2018 held under the auspices of the Worldwide Network for Blood and Marrow Transplantation (WBMT)","volume":"13","author":"Harif","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"3","key":"2021121012064779400_hem2021000258C52","doi-asserted-by":"crossref","first-page":"267.e1","DOI":"10.1016\/j.jtct.2020.12.015","article-title":"Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations regarding essential medications required to establish an early stage hematopoietic cell transplantation program","volume":"27","author":"El Fakih","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"2021121012064779400_hem2021000258C53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.hemonc.2019.08.002","article-title":"Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (part II): clinical, technical and socio-economic considerations","volume":"13","author":"Aljurf","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"2","key":"2021121012064779400_hem2021000258C54","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/jama.2015.13706","article-title":"Global use of peripheral blood vs bone marrow as source of stem cells for allogeneic transplantation in patients with bone marrow failure","volume":"315","author":"Yoshimi","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"2021121012064779400_hem2021000258C55","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.bbmt.2020.08.018","article-title":"The global state of hematopoietic cell transplantation for multiple myeloma: an analysis of the Worldwide Network of Blood and Marrow Transplantation database and the global burden of disease study","volume":"26","author":"Cowan","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2021121012064779400_hem2021000258C56","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41409-019-0476-6","article-title":"Worldwide Network for Blood and Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries","volume":"54","author":"Aljurf","year":"2019","journal-title":"Bone Marrow Transplant"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2021\/1\/264\/1851868\/264rocha.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2021\/1\/264\/1851868\/264rocha.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T07:12:02Z","timestamp":1639120322000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2021\/1\/264\/482965\/Increasing-access-to-allogeneic-hematopoietic-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,10]]},"published-print":{"date-parts":[[2021,12,10]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2021000258","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,10]]},"published":{"date-parts":[[2021,12,10]]}}}